BACKGROUND: @entity15 ( @entity15 ) causes not only somatic, but also @entity73 regardless of the @entity1 *  age or the course of the disease. The Brief International Cognitive Assessment for @entity15 (BICAMS) test, published in 2011, is a short cognitive questionnaire: a fast, reliable, sensitive and specific tool for the evaluation of the @entity1 *  cognitive state. OBJECTIVES: Our primary objective was to assess the validity of the Hungarian version of the BICAMS test. Our secondary objective was to evaluate the impact of the @entity73 on the @entity1 * s quality of life and @entity1295 * s impact on the @entity1 *  cognitive state. METHODS: 65 RR- @entity15 @entity1 and 65 age, sex and education matched healthy control (HC) subjects completed the test and were retested after 3 weeks. The @entity1 also completed the @entity15 Quality of Life 54 (MSQoL54) and the Fatigue Impact Scale (FIS) assessments. Group differences were calculated by paired sample T-tests. The test-retest reliability was measured by intraclass correlation coefficients. To analyze the difference between the test-retest performances of the two groups we used two-way repeated measures ANOVA where the BICAMS battery was the single composite outcome and one-way repeated measures ANOVA. To assess the impact of the @entity73 on the @entity1 *  quality of life and @entity1295 * s impact on the cognitive state, we examined the correlations between results in the BICAMS and the MSQoL54 and FIS. RESULTS: We found significant difference (p <=0.001, p=0.017 in the first CVLT-II assessment) between @entity15 @entity1 and members of the HC group in all four evaluated parameters of BICAMS test in both sessions. The correlation coefficients were very strong between the tests and retests (r>0.8; p<0.001; r=0.678, p<0.001 between the CVLT-II assessments). We found that the HC group performed significantly (p=0.020) better in the retest sessions as compared to their original performance than the @entity1 did and this difference is solely due to the difference between the CVLT-II performances. We have found significant negative correlation between the @entity1 *  cognitive function and the @entity1295 score (r<-0.3, p<0.05). Seven of the MSQoL-54 subscales correlated with the BICAMS performance (r>0.3; p<0.05). CONCLUSIONS: The Hungarian version of the BICAMS test is a valid and reliable method for the evaluation of @entity15 @entity1 *  cognitive function. It seems that because of the short retest period, the members of the HC group remembered the CVLT-II words thus performed better than the @entity1 did. Also apparently @entity1295 can have a negative impact on the @entity1 *  cognitive state, and @entity73 could worsen the @entity1 *  quality of life.

The Hungarian validation of the Brief International Cognitive Assessment for @entity15 (BICAMS) battery and the correlation of @entity73 with XXXX and quality of life.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity73 :: ('MESH:D003072', 'Disease') :: ['cognitive impairment', 'cognitive decline'] @entity15 :: ('MESH:D009103', 'Disease') :: ['MS', 'Multiple Sclerosis'] @entity1295 :: ('MESH:D005221', 'Disease') :: ['fatigue']
@entity1295 :: (MESH:D005221,Disease) :: ['fatigue']
